Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: acceptable well documented study report which meets basic scientific principles

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1976

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Radio-labeled indometacin and acemetacin (with 14-C) were applied to male rats by the oral, intravenous and intraduodenal route in equimolar dosages. Radioactivity was measunred in excreta, secretions and tissues.

Test material

Constituent 1
Chemical structure
Reference substance name:
Indometacin
EC Number:
200-186-5
EC Name:
Indometacin
Cas Number:
53-86-1
Molecular formula:
C19H16ClNO4
IUPAC Name:
2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid
Details on test material:
test material radiolabeled with 14-C; , 30µCi/mg, radiochemical purity: > 99%
Radiolabelling:
yes
Remarks:
14-C

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male

Administration / exposure

Route of administration:
oral: gavage
Duration and frequency of treatment / exposure:
single administration
Doses / concentrations
Remarks:
Doses / Concentrations:
5 mg/kg bw (2 mL/animal)
No. of animals per sex per dose / concentration:
5

Results and discussion

Toxicokinetic / pharmacokinetic studies

Details on absorption:
Resorption was 80% or more
Details on distribution in tissues:
One hour after oral administration, 50-60% of radioactivity (less gastrointestinal tract) was in the animal. The highest concentration was in serum. Six hours after administration, high concentrations were seen in liver, kidney and still serum. Low concentrations occurred in brain and musculature. Relatively high activity in serum indicates a low volume of distribution of test material and metabolites. Whole body autoradiography after 3 min, and 1,3, and 6 hours confirmed the distribution pattern and revealed transient accumulation in brown adipose tissue, collagen connective tissue and salivary gland at the throat.
Details on excretion:
Within 48 hours after oral and intravenous administration 30-40 of radioactivity was renally eliminated, about 6% of acitivity was metabolized to 14-C-carbondioxide. The rest (approx. 55-60%) was eliminated by the feces. After 48 hours, 1-2% of radioactivity remain in the animal (gastro-intestinal tract not included). After intraduodenal administration, the resorbed activity was mainly eliminated via bile and partly re-resorbed, showing enterohepatic circulation.

Applicant's summary and conclusion